Our Pricing

Wegovy Private Prescription UK: Fast Access Without NHS Delays

Published on: June 03, 2026

Securing a wegovy private prescription uk service means you can bypass NHS waiting lists and access clinically proven weight loss treatment within days. At Cured Pharmacy, our UK-registered prescribers assess your suitability through a free online consultation, with genuine UK-licensed Wegovy pens available from £79.00 and discreet next-day delivery across the UK.

How Wegovy Private Prescription UK Services Work

A wegovy private prescription uk pathway allows you to access semaglutide 2.4mg injections without the lengthy NHS referral process. You complete a clinical assessment online, which is reviewed by a UK-registered prescriber from our team. If clinically appropriate, your prescription is issued the same day and dispensed by our GPhC-registered pharmacy (9012511), overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the body's natural incretin hormones to regulate appetite and food intake [1]. In the STEP 1 trial, participants achieved an average 14.9% body weight reduction over 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo [1]. This makes it one of the most effective pharmacological weight management options licensed by the MHRA.

Why Choose Private Wegovy Prescription Over NHS Routes

NHS weight management services face significant capacity constraints, with waiting times often extending 6-12 months in many Clinical Commissioning Groups. NICE guidelines recommend GLP-1 treatments like Wegovy for adults with a BMI ≥30 kg/m² (or ≥27 kg/m² with weight-related comorbidities), but access remains limited due to funding pressures [2].

Private prescription services eliminate these delays entirely. At Cured Pharmacy, eligible patients can complete their consultation in under 3 minutes and receive their first Wegovy pen within 24-48 hours. You maintain full control over your treatment schedule, with transparent upfront pricing and no hidden consultation fees.

Clinical Eligibility Criteria

Our UK prescribers follow the same MHRA-approved clinical criteria as NHS services. You may be suitable for Wegovy if you have a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Your prescriber will review your medical history, current medications, and contraindications during the online assessment to ensure Wegovy is safe and appropriate for you.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a structured dose-escalation protocol designed to minimise gastrointestinal side effects while optimising weight loss outcomes. You begin with 0.25mg once weekly for four weeks, then increase monthly through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly [3].

This gradual titration allows your body to adapt to semaglutide's effects on gastric emptying and satiety signalling. Most patients report reduced appetite within the first two weeks, with measurable weight loss typically evident by week 4-6. Clinical trial data shows that approximately 86% of participants achieved at least 5% body weight reduction by week 68, with nearly half losing 15% or more [1].

Managing Side Effects During Titration

The most common side effects are gastrointestinal — nausea, diarrhoea, constipation, and occasional vomiting — which tend to be mild to moderate and decrease over time [3]. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these symptoms. If side effects become problematic, your prescriber may recommend staying at your current dose for an additional week before increasing further.

Wegovy Cost Comparison: Private vs NHS Pricing

At Cured Pharmacy, Wegovy pens start from £79.00 per pen, with the exact cost depending on your prescribed dose strength. This represents competitive UK pricing compared to typical market rates, and we guarantee transparent pricing before you complete your consultation — no hidden fees or surprise charges.

For NHS patients who do gain access, Wegovy is typically provided at standard prescription charges (currently £79.00 per item in England, free in Scotland and Wales). However, the opportunity cost of waiting months for an initial appointment, plus the risk of regional variation in availability, often makes private prescription the more practical option for patients ready to begin treatment immediately.

How Long Does Wegovy Private Prescription Treatment Last

Wegovy is intended as a long-term weight management treatment, not a short-term intervention. NICE guidance suggests continuing treatment as long as it remains clinically beneficial and well-tolerated [2]. In clinical practice, this often means 12-24 months of active treatment, with ongoing lifestyle modification support.

Your UK prescriber will conduct regular reviews every 3-6 months to assess your progress, monitor for adverse effects, and determine whether continuing Wegovy remains appropriate. If you achieve your target weight and maintain it for several months with stable lifestyle habits, your prescriber may discuss a supervised discontinuation plan. However, many patients require ongoing treatment to sustain weight loss, as obesity is a chronic relapsing condition [2].

What Happens If You Stop Wegovy

Clinical data from extension studies shows that most patients regain a significant portion of lost weight within 12 months of stopping semaglutide, unless lifestyle changes are rigorously maintained [4]. This isn't a treatment failure — it reflects the biological mechanisms that defend against sustained weight loss. Your prescriber will work with you to develop a realistic long-term plan, whether that involves continued pharmacotherapy, intermittent treatment cycles, or transitioning to alternative weight management strategies.

Starting Your Wegovy Private Prescription UK Journey

Beginning treatment at Cured Pharmacy takes three simple steps. First, complete our free online consultation form, which covers your medical history, current health conditions, and weight management goals. Second, a UK-registered prescriber reviews your assessment within hours and determines your suitability for Wegovy. Third, if approved, your prescription is dispensed from our GPhC-registered pharmacy and shipped in 100% discreet packaging with next-day delivery options available.

We supply only genuine UK-licensed Wegovy pens manufactured by Novo Nordisk, complete with patient information leaflets and full prescribing documentation. Every prescription includes access to our clinical support team, who can answer questions about injection technique, side effect management, and treatment optimisation throughout your journey. You'll also receive automatic reminders when it's time to reorder, ensuring you never miss a dose.

Ongoing Support and Prescription Renewals

Weight loss treatment works best with consistent clinical oversight. Our prescribers will request periodic updates on your progress, including weight measurements and any side effects you're experiencing. Prescription renewals require a brief follow-up consultation to ensure Wegovy remains safe and effective for you. This ongoing relationship ensures you receive the same standard of care you'd expect from traditional pharmacy services, with the added convenience of digital access and home delivery.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.